0 citations0 referencesGoogle Scholardoi.orgBioequivalence and the immunogenicity of biopharmaceuticalsNature Reviews Drug Discovery·2002·Vol. 1(6), pp. 457–462Citations Over TimeTop 10% of 2002 papersHuub SchellekensRelated Papers→ Biologics and biosimilars(2015)50 cited→ Practical Considerations for Integrating Biosimilars Into Clinical Practice(2021)2 cited→ Innovator Biologics, Biosimilars, and Biobetters(2020)3 cited→ BIOSIMILARS NEED OF THE FUTURE(2014)